Search results
Speaking Up and Speaking Out About Breast Cancer
Parade via Yahoo News· 2 years agoHow one woman is using her journey with the disease—and her experience with the Oncotype DX Breast Recurrence Score test—to help others. When Punita K....
UK NICE backs Exact’s Oncotype cancer genomic test
Medical Device Network via Yahoo Finance· 5 days agoThe UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Exact Sciences’s genomic test Oncotype DX breast recurrence...
The Exact Sciences Corp (EXAS) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 6 months agoExact Sciences Corp (NASDAQ:EXAS) has seen a 20% increase in revenue in Q3 2023 compared to the same...
Exact Sciences (EXAS) Aided by Innovation, Strategic Buyouts
Zacks via Yahoo Finance· 7 months agoExact Sciences EXAS is continually making significant progress with its Cologuard test. Strategic...
Here's Why You Should Retain Exact Sciences (EXAS) Stock Now
Zacks via Yahoo Finance· 7 months agoExact Sciences Corporation EXAS is likely to grow in the coming quarters, led by the broad-based...
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
Zacks via Yahoo Finance· 1 year agoExact Sciences Corporation EXAS is set to report fourth-quarter 2022 results on Feb 21, after the...
7 Nasdaq Stocks to Buy on the Dip or You’ll Be Kicking Yourself Later
InvestorPlace via Yahoo Finance· 2 years agoFor a few months, I’ve believed that both inflation and stocks were bottoming. Now prominent...
Local breast cancer survivor made sure it didn't take her identity, discovered unexpected inner...
Watertown Daily Times, N.Y. via Yahoo News· 2 years agoOct. 21—CLAYTON — While breast cancer — and cancer in general — takes and takes, one thing Heather M. Delperuto is confident in is that it can't take who she is or how she looks at life. A new ...
